Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Facing the Inevitable: Being Prepared for Regulatory Requirements for Laboratory Developed Tests.

PMID: 29659675 ·

R, i, t, a, , D, ', A, n, g, e, l, o, ;, , R, o, n, a, l, d, , W, e, i, s, s, ;, , D, a, v, i, d, , W, o, l, f, e, ;, , R, a, t, n, a, , C, h, i, n, n, a, m, ;, , A, l, p, e, r, , M, u, r, a, t, ;, , J, u, l, i, a, , G, l, u, e, s, i, n, g, ;, , T, o, n, i, , S, o, m, e, r, s

RevistaAmerican journal of clinical pathology
Año
PMID29659675

Resumen

We introduce regulatory terms, definitions, and the Quality System Regulation as proposed by the US Food and Drug Administration in the 2014 draft guidance entitled Framework for Regulatory Oversight of Laboratory Developed Tests and explore medical device requirements applicable to a laboratory environment to design, develop, and validate laboratory developed tests (LDTs). We performed nine interviews with laboratory professionals to explore concerns and challenges regarding the draft, translat

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑